Your session is about to expire
← Back to Search
Sequential vs. Standard Laser Treatment for TTTS
Study Summary
This trial is comparing two methods of treating TTTS to see which one is better. The first method is SQLPCV and the second is SLPCV. They are comparing the perinatal outcomes of each method.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a major birth defect that doesn't require surgery.I have had a procedure to intentionally create a hole in the heart's dividing wall.I am pregnant with twins or triplets sharing a placenta and have TTTS with specific ultrasound findings.I have an abnormal number of chromosomes.The doctor in charge of the study decides that you are not a good fit for the study.My unborn baby has abnormal brain ultrasound findings.Your water has broken.I am unable to sign a consent form.You have experienced separation of the placenta from the uterus before the baby is born.I am not willing to receive blood transfusions.I am willing and able to participate in the study and follow-up.
- Group 1: Selective procedure
- Group 2: Sequential procedure
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment open for this trial at this time?
"As indicated by the clinicaltrials.gov website, this experiment is enlisting participants and has been doing so since June 1st 2010 with its most recent update occurring on May 6th 2022."
What is the total number of individuals participating in this research project?
"Affirmative, the clinicaltrials.gov website states that recruitment for this research project is still active. Initially posted on June 1st 2010 and last updated on May 6th 2022, the trial has a goal of enrolling 542 participants at one location."
Could I be involved with this medical experiment?
"The requirements for entry into this medical research are twin-twin transfusion syndrome and an age between 16 to 55. Upwards of 542 individuals will be accepted in the trial."
Does this research incorporate participants who are older than 30?
"This medical experiment has a strict age limit of 16-55 years old, with 377 trials available for minors and 989 studies open to individuals over 65."
Share this study with friends
Copy Link
Messenger